Common Stock |
9 Months Ended |
|---|---|
Jul. 31, 2026 | |
| Common Stock [Abstract] | |
| COMMON STOCK | NOTE 11 – COMMON STOCK
During the nine months ended July 31, 2026, 45,000 warrants to acquire 45,000 shares of common stock were exercised at an exercise price of $CDN 0.13 per share of common stock for aggregate gross proceeds of $4,213.
The Company incurred costs of $334 related to warrant exercises in the nine months ended July 31, 2026.
During the nine months ended July 31, 2025, 245,000 warrants to acquire 245,000 shares of common stock were exercised at an exercise price of $0.59 per share of common stock for aggregate gross proceeds of $144,550, of which $0.25 per share was paid to Arras ($61,250).
The Company incurred costs of $1,544 related to warrant exercises in the nine months ended July 31, 2025. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|